Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Chicago Sun-Times
Chicago Sun-Times
World
Associated Press

Justice Ginsburg reveals cancer has returned, but she won’t retire

U.S. Supreme Court Associate Justice Ruth Bader Ginsburg speaks during a discussion on the 100th anniversary of the ratification of the 19th Amendment at Georgetown University Law Center in Washington. in February. | AP

WASHINGTON — Justice Ruth Bader Ginsburg said Friday she is receiving chemotherapy for a recurrence of cancer, but has no plans to retire from the Supreme Court.

The 87-year-old Ginsburg, who spent time in the hospital this week for a possible infection, said her treatment so far has succeeded in reducing lesions on her liver and that she will continue chemotherapy sessions every two weeks.

“I have often said I would remain a member of the Court as long as I can do the job full steam. I remain fully able to do that,” Ginsburg said in a statement issued by the court.

She said her recent hospitalizations, including one in May, were unrelated to the cancer.

A medical scan in February revealed growths on her liver, she said, and she began chemotherapy in May.

“My most recent scan on July 7 indicated significant reduction of the liver lesions and no new disease,” she said. “I am tolerating chemotherapy well and am encouraged by the success of my current treatment.”

Ginsburg, who was appointed by President Bill Clinton and joined the court in 1993, has been treated four times for cancer. In addition to the tumor on her pancreas last year, she was previously treated for colorectal cancer in 1999 and pancreatic cancer in 2009. She had lung surgery to remove cancerous growths in December 2018.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.